Phase 2 cagrilintide alone ~10.8% body weight reduction at 26 weeks (4.5mg) Phase 2 CagriSema combo ~15.6% body weight reduction at 32 weeks Phase 3 REDEFINE 1 ~22.7% body weight reduction at 68 weeks Phase 2 CagriSema combination trial The Phase 2 trial of CagriSema was published in The Lancet in 2023, and its results attracted immediate attention
From a practical perspective, this can support: Cellular repair Lean tissue maintenance Fat oxidation during caloric restriction Sleep quality and recovery It may also be combined with Ipamorelin for complementary GH stimulation or with GHK-Cu when connective tissue repair is part of the clinical goal
Spiekermann GM, Finn PW, Ward ES, Dumont J, Dickinson BL, Blumberg RS, et al
Eating small, frequent meals can also prevent blood pressure drops that occur after large meals
(B) Query of PDMP (Measure ID # PI_EP_2)
Why quality bac water makes the 28-day window meaningful The 28-day rule assumes USP-spec bac water at day zero
